Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Kelloff

Showing results (1-10 of 235) with videos related to

Pageof 24
Sort By:
Advances in Cancer Research|November 5, 1999
Perspectives on cancer chemoprevention research and drug developmentG J Kelloff
IARC Scientific Publications|January 1, 1996
The role of chemoprevention in cancer controlP Greenwald, G J Kelloff
Experimental Lung Research|March 1, 1991
Histologic characterization of mouse bronchiolar cell hyperplasia, metaplasia, and neoplasia induced intratracheally by 3-methylcholanthreneS Rehm, G J Kelloff
Cancer Surveys|September 18, 1999
Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysisC W Boone, G J Kelloff
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasiaC W Boone, G J Kelloff
Journal of Cellular Biochemistry. Supplement|April 13, 2000
Endpoint markers for cancer chemoprevention trials derived from the lesion of precancer (intraepithelial neoplasia) measured by computer-assisted quantitative image analysisC W Boone, G J Kelloff
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemopreventionC W Boone, G J Kelloff
Journal of the National Cancer Institute|June 7, 1989
Chemoprevention strategies utilizing combinations of inhibitors of carcinogenesisW F Malone, G J Kelloff
IARC Scientific Publications|January 1, 1997
Biomarker end-points in cancer chemoprevention trialsC W Boone, G J Kelloff
Prostate Cancer and Prostatic Diseases|December 24, 2002
Strategies for chemoprevention of prostate cancerG J Kelloff, R Lieberman, M K Brawer, et al.
Pageof 24

Showing results (1-10 of 235) with videos related to

Sort By:
Pageof 24
Advances in Cancer Research|November 5, 1999
Perspectives on cancer chemoprevention research and drug developmentG J Kelloff
IARC Scientific Publications|January 1, 1996
The role of chemoprevention in cancer controlP Greenwald, G J Kelloff
Experimental Lung Research|March 1, 1991
Histologic characterization of mouse bronchiolar cell hyperplasia, metaplasia, and neoplasia induced intratracheally by 3-methylcholanthreneS Rehm, G J Kelloff
Cancer Surveys|September 18, 1999
Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysisC W Boone, G J Kelloff
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasiaC W Boone, G J Kelloff
Journal of Cellular Biochemistry. Supplement|April 13, 2000
Endpoint markers for cancer chemoprevention trials derived from the lesion of precancer (intraepithelial neoplasia) measured by computer-assisted quantitative image analysisC W Boone, G J Kelloff
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemopreventionC W Boone, G J Kelloff
Journal of the National Cancer Institute|June 7, 1989
Chemoprevention strategies utilizing combinations of inhibitors of carcinogenesisW F Malone, G J Kelloff
IARC Scientific Publications|January 1, 1997
Biomarker end-points in cancer chemoprevention trialsC W Boone, G J Kelloff
Prostate Cancer and Prostatic Diseases|December 24, 2002
Strategies for chemoprevention of prostate cancerG J Kelloff, R Lieberman, M K Brawer, et al.
Pageof 24